Acute myeloid leukemia (AML) is a fast-growing cancer of the blood and bone marrow. It develops when immature myeloid cells grow uncontrollably, interfering with the production of healthy blood cells. Because AML can progress rapidly, early diagnosis and prompt treatment are essential. Advances in targeted therapies and supportive care have improved outcomes for many patients, with treatment plans tailored to the specific type of AML and the individual's overall health.
AML begins in the bone marrow, where blood cells are produced.
As abnormal leukemia cells multiply, they crowd out healthy blood-forming cells, which can lead to:
AML is most common in adults, although it can occur at any age.
Symptoms often develop over days or weeks and may include:
These symptoms can also occur with other medical conditions and require prompt evaluation.
Factors associated with an increased risk of AML include:
Many people diagnosed with AML have no identifiable risk factors.
Healthcare providers may use several tests to diagnose AML, including:
These tests help confirm the diagnosis and guide treatment decisions.
Treatment depends on the subtype of AML, genetic findings, age, and overall health.
Possible treatments include:
Some people receive a combination of these treatments.
Supportive treatment plays an important role throughout therapy.
It may include:
These measures help reduce complications and improve treatment tolerance.
Regular follow-up helps assess how well treatment is working.
Monitoring may involve:
Results guide future treatment decisions.
People receiving treatment for AML should seek prompt medical attention if they develop:
These symptoms may require urgent evaluation and treatment.
Acute myeloid leukemia is a rapidly progressing blood cancer that requires timely diagnosis and specialized care. Modern treatment may include chemotherapy, targeted therapies, stem cell transplantation, and comprehensive supportive care, depending on the individual's disease characteristics. Advances in diagnostic testing and personalized treatment have improved outcomes for many patients, making early medical evaluation and ongoing care essential throughout the treatment journey.